01 2Pierre Fabre Dermo Cosmetique
02 1Pierre Fabre Dermo-Cosmetique
03 3Pierre Fabre Medicament
04 3Pierre Fabre Pharmaceuticals, Inc.
01 1No Action Indicated
02 8Voluntary Action Indicated
01 12024-11-01
02 12022-07-27
03 12019-09-20
04 12018-07-13
05 12016-04-15
06 12015-12-30
07 22015-01-16
08 12013-03-14
01 3Avene
02 3Gaillac
03 3Parsippany
01 6France
02 3U.S.A
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-11-01
City : Parsippany
State : New Jersey
Country/Area : U.S.A
Zip : 7054
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2024-11-01
District Decision : Voluntary Action Indicated
Inspection End Date : 2022-07-27
City : Parsippany
State : New Jersey
Country/Area : U.S.A
Zip : 7054
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2022-07-27
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-20
City : Avene
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2019-09-20
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-07-13
City : Gaillac
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-07-13
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-04-15
City : Gaillac
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2016-04-15
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-12-30
City : Parsippany
State : New Jersey
Country/Area : U.S.A
Zip : 7054
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-12-30
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
City : Avene
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
City : Avene
State :
Country/Area : France
Zip :
District : ORA
Center : CFSAN
Project Area : Colors and Cosmetics Technology
District Decision : Voluntary Action Indicated
Inspection End Date : 2015-01-16
District Decision : No Action Indicated
Inspection End Date : 2013-03-14
City : Gaillac
State :
Country/Area : France
Zip :
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2013-03-14
Pierre Fabre is a supplier offers 15 products (APIs, Excipients or Intermediates).
Find a price of Vinorelbine Tartrate bulk with DMF, CEP, JDMF offered by Pierre Fabre
Find a price of Milnacipran Hydrochloride bulk with DMF, JDMF offered by Pierre Fabre
Find a price of Chondroitin Sulfate Sodium bulk with CEP offered by Pierre Fabre
Find a price of Ciclopirox bulk offered by Pierre Fabre
Find a price of HYDROXYPROPYLMETHYLCELLULOSE bulk with CEP offered by Pierre Fabre
Find a price of Levomilnacipran bulk with DMF offered by Pierre Fabre
Find a price of Vinflunine Ditartrate bulk with DMF offered by Pierre Fabre
Find a price of Mucoproteose bulk with CEP offered by Pierre Fabre
Find a price of Ciclopirox Olamine bulk offered by Pierre Fabre
Find a price of HYDROXYPROPYLMETHYLCELLULOSE bulk offered by Pierre Fabre
Find a price of Idazoxan bulk offered by Pierre Fabre
Find a price of Milnacipran Hydrochloride bulk offered by Pierre Fabre
Find a price of Vinflunine Ditartrate bulk offered by Pierre Fabre
Find a price of Vinorelbine Tartrate bulk offered by Pierre Fabre
Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GAILLAC, FRANCE. bulk offered by Pierre Fabre
